Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-11

FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for pantoprazole sodium filed by Novadoz Pharmaceuticals LLC. This action updates the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)